Cargando…

Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma

BACKGROUND: Epidermal growth factor receptor (EGFR) is frequently overexpressed in oral squamous cell carcinoma (OSCC), and EGFR‐targeting therapeutics have been widely employed to treat patients with a variety of carcinomas including OSCC. Here, we aimed to investigate alternative signaling for OSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onda, Maho, Ota, Akinobu, Ito, Kunihiro, Ono, Takayuki, Karnan, Sivasundaram, Kato, Mikako, Kondo, Sayuri, Furuhashi, Akifumi, Hayashi, Tomio, Hosokawa, Yoshitaka, Kazaoka, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469792/ https://www.ncbi.nlm.nih.gov/pubmed/37341071 http://dx.doi.org/10.1002/cam4.6282

Ejemplares similares

Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma
por: Kondo, Sayuri, et al.
Publicado: (2020)

Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide
por: Karnan, Sivasundaram, et al.
Publicado: (2016)

Simple Monitoring of Gene Targeting Efficiency in Human Somatic Cell Lines Using the PIGA Gene
por: Karnan, Sivasundaram, et al.
Publicado: (2012)

A Comparative Analysis of Constitutive Promoters Located in Adeno-Associated Viral Vectors
por: Damdindorj, Lkhagvasuren, et al.
Publicado: (2014)

Novel ATP‐competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
por: Yamaji, Masayuki, et al.
Publicado: (2017)

Flow cytometry-based quantification of targeted knock-in events in human cell lines using a GPI-anchor biosynthesis gene PIGP
por: Rahman, Md. Lutfur, et al.
Publicado: (2021)

Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking
por: Rahman, Md. Lutfur, et al.
Publicado: (2021)

Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene
por: Hasan, Muhammad Nazmul, et al.
Publicado: (2023)

Establishment and characterization of CRISPR/Cas9‐mediated NF2 (−/−) human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma
por: Wahiduzzaman, Md, et al.
Publicado: (2018)

Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines
por: Inukai, Daisuke, et al.
Publicado: (2020)

Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells
por: Kanasugi, Jo, et al.
Publicado: (2020)

BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022)

Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
por: Karnan, Sivasundaram, et al.
Publicado: (2020)

Treatment outcome of oral appliance in patients with REM-related obstructive sleep apnea
por: Nishio, Yoshitomo, et al.
Publicado: (2019)

Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells
por: Ota, Akinobu, et al.
Publicado: (2017)

Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells
por: Ota, Akinobu, et al.
Publicado: (2020)

CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma
por: Karnan, Sivasundaram, et al.
Publicado: (2023)

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
por: Yuan, Xiao-Han, et al.
Publicado: (2018)

Establishment and characterization of a novel vincristine‐resistant diffuse large B‐cell lymphoma cell line containing the 8q24 homogeneously staining region
por: Mizuno, Shohei, et al.
Publicado: (2018)

Tumor‐infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma
por: Hayashi, Tomio, et al.
Publicado: (2021)

CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
por: Karnan, Sivasundaram, et al.
Publicado: (2021)

Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells
por: Azami, Yusuke, et al.
Publicado: (2021)

Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
por: Longatto-Filho, Adhemar, et al.
Publicado: (2009)

Array-comparative genomic hybridization profiling of immunohistochemical subgroups of diffuse large B-cell lymphoma shows distinct genomic alterations
por: Guo, Ying, et al.
Publicado: (2014)

ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
por: Ryan, A J, et al.
Publicado: (2005)

Case report of Pierre Robin sequence with severe upper airway obstruction who was rescued by fiberoptic nasotracheal intubation
por: Takeshita, Satoru, et al.
Publicado: (2017)

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
por: Saleh, Nashwa M., et al.
Publicado: (2020)

Combined EGFR and VEGFR versus Single EGFR Signaling Pathways Inhibition Therapy for NSCLC: A Systematic Review and Meta-Analysis
por: Zhang, Xinji, et al.
Publicado: (2012)

DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1
por: Duan, Yang, et al.
Publicado: (2016)

Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells
por: Valverde, Araceli, et al.
Publicado: (2015)

Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
por: Sun, Shaofeng, et al.
Publicado: (2017)

Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
por: Kaufman, Nichole E. M., et al.
Publicado: (2021)

Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer
por: Osude, Chike, et al.
Publicado: (2022)

Clinicopathological impact of VEGFR2 and VEGF‐C in patients with EGFR ‐major mutant NSCLC receiving osimertinib
por: Kaira, Kyoichi, et al.
Publicado: (2023)

VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis
por: Jang, Jeon Yeob, et al.
Publicado: (2017)

Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
por: Yoshikawa, D, et al.
Publicado: (2009)

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
por: Morgillo, Floriana, et al.
Publicado: (2011)

Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens
por: Yamanaka, Shunpei, et al.
Publicado: (2023)

Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study
por: Nishio-Nagai, Mayako, et al.
Publicado: (2017)

Cytotoxicity of Callerya speciosa Fractions against Myeloma and Lymphoma Cell Lines
por: Lam, Vu Quang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0f4dg5u8l3uj4lce3hl1clj7u8